Woodcock Named Acting Chief as FDA Awaits Permanent Commissioner
February 2, 2021
Janet Woodcock stepped into her new role as acting FDA Commissioner last month, pledging in an email to agency staff to maintain the agency’s science-based approach. “The American people can be certain that science — above all — will continue to guide the FDA’s regulatory actions now and into the future,” she said.